Researchers Advance Gene Therapy for CLIC5-Related Inner Ear Dysfunction
The therapy targets mutations in the CLIC5 gene, which affect hair cell stability and lead to progressive hearing and balance impairments.
The therapy targets mutations in the CLIC5 gene, which affect hair cell stability and lead to progressive hearing and balance impairments.
Understanding how and why people react to background noise could help in finding effective intervention strategies.
Investigational gene therapy DB-OTO showed promising improvements in hearing and speech development in children with otoferlin-related genetic hearing loss.
Amptify introduced a new curriculum that is designed to support individuals with unique auditory challenges.
In an article published on the ”Discover Magazine” website, author Sarah Katz challenges the view in the scientific community that deafness is a problem that needs to be cured, potentially by new CRISPR technology that could eliminate a TMC1 gene mutation.
The Ear Science Institute Australia's project on sensorineural hearing loss treatment will receive research support from MedChem Australia.
Sound Pharmaceuticals has completed a Phase 3 clinical trial for SPI-1005, a novel anti-inflammatory treatment for Meniere’s Disease, showing potential improvements in hearing loss and tinnitus.